Bank of America Corporation »

Relmada Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2024-09-30 $670k 207k 3.24
2024-06-30 $624k 208k 3.00
2024-03-31 $979k 211k 4.65
2023-12-31 $872k 211k 4.14
2023-09-30 $641k 214k 3.00
2023-06-30 $583k 237k 2.46
2023-03-31 $84k 37k 2.26
2022-12-31 $58k 17k 3.49
2022-06-30 $167k 8.8k 18.95
2021-12-31 $235k 10k 22.58
2021-06-30 $199k 6.2k 32.05
2021-03-31 $274k 7.8k 35.25
2020-12-31 $187k 5.8k 32.12
2020-09-30 $284k 7.6k 37.57
2020-06-30 $394k 8.8k 44.74
2020-03-31 $476k 14k 34.09